National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 284165

History of Changes from the VAERS Wayback Machine

First Appeared on 12/8/2009

284165
VAERS Form:
Age:20.0
Gender:Female
Location:Unknown
Vaccinated:2007-03-30
Onset:2007-03-30
Submitted:2007-06-14
Entered:2007-06-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0188U / 0 UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Headache

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit? (V2.0) No
Hospitalized? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: Unknown
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': WAES0705USA03896

Write-up:Information has been received from a registered nurse concerning a 20 year old female patient who on 30-MAR-2007 was vaccinated with a first 0.5ml dose of Gardasil (Lot# 657006/0188U). On 30-MAR-2007 the patient experienced a severe headache. The patient went to the ER but it was not known if she was admitted. On an unspecified date, the patient recovered. On the morning of 21-MAY-2007 the patient received a second dose of the vaccine (Lot#657737/0522U) and no experience was reported. No product quality complaint was involved. Additional information has been requested.


Changed on 3/2/2010

284165 Before After
VAERS Form:
Age:20.0
Gender:Female
Location:Unknown
Vaccinated:2007-03-30
Onset:2007-03-30
Submitted:2007-06-14
Entered:2007-06-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0188U / 0 UN / UN IM

Administered by: Other      Purchased by: Other
Symptoms: Headache

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit? (V2.0) No
Hospitalized? No
Previous Vaccinations:
Other Medications: Unknown Albuterol
Current Illness: Migraine; asthma; drug hypersensitivity; sulfonemdiea llergy; acetaminophen
Preexisting Conditions: Unknown Lung disorder; Neurological disorder NOS: Hypersensitivity
Allergies:
Diagnostic Lab Data: Neurological examination, normal; head computed axial, normal
CDC 'Split Type': WAES0705USA03896

Write-up:Information has been received from a registered nurse concerning a 20 year old female patient who on 30-MAR-2007 was vaccinated with a first 0.5ml dose of Gardasil GARDASIL (Lot# 657006/0188U). On 30-MAR-2007 the patient experienced a severe headache. The patient went to the ER but it was not known if she was admitted. On an unspecified date, the patient recovered. On the morning of 21-MAY-2007 the patient received a second dose of the vaccine (Lot#657737/0522U) and no experience was reported. No product quality complaint was involved. Additional information has been requested. This is in follow-up to report (s) previously submitted on 6/14/2007. Information has been received from a registered nurse concerning a 20 year old female student with a history of migraine, asthma and allergies to acetaminophen, codeine, hydrocodone, sulfa, and VICODIN who on 20-MAR-2007, was vaccinated with a first dose 0.5ml dose of GARDASIL (lOT# 657006/0188u). On 20-MAR-2007 the patient experienced a severe headache. The patient went to the ER the day after receiving her vaccination. She reported feeling unclear during the injection and developed a diffuse headache, worse than a migraine and not relieved with MOTRIN or TORADOL. Laboratory diagnostic studies performed were a neurological exam and a CT scan which were both reported to be normal. The headache improved with DILAUDID. The patient was discharged with instructions to follow up with her primary care physician to continue GARDASIL series. Within on to two days, the patient recovered. On the morning of 21-MAY-2007, the patient received a second dose of the vaccine (Lot#657737/0522U) and no experience was reported. No product quality complaint was involved. It was reported that the patient''s headache was most likely a side effect from the vaccine. Additional information is not expected.


Changed on 4/7/2010

284165 Before After
VAERS Form:
Age:20.0
Gender:Female
Location:Unknown
Vaccinated:2007-03-30
Onset:2007-03-30
Submitted:2007-06-14
Entered:2007-06-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0188U / 0 UN / IM

Administered by: Other      Purchased by: Other
Symptoms: Computerised tomogram normal, Headache, Neurological examination

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit? (V2.0) No
Hospitalized? No
Previous Vaccinations:
Other Medications: Albuterol
Current Illness: Migraine; asthma; drug hypersensitivity; sulfonemdiea llergy; acetaminophen
Preexisting Conditions: Lung disorder; Neurological disorder NOS: Hypersensitivity
Allergies:
Diagnostic Lab Data: Neurological examination, normal; head computed axial, normal
CDC 'Split Type': WAES0705USA03896

Write-up:Information has been received from a registered nurse concerning a 20 year old female patient who on 30-MAR-2007 was vaccinated with a first 0.5ml dose of GARDASIL (Lot# 657006/0188U). On 30-MAR-2007 the patient experienced a severe headache. The patient went to the ER but it was not known if she was admitted. On an unspecified date, the patient recovered. On the morning of 21-MAY-2007 the patient received a second dose of the vaccine (Lot#657737/0522U) and no experience was reported. No product quality complaint was involved. Additional information has been requested. This is in follow-up to report (s) previously submitted on 6/14/2007. Information has been received from a registered nurse concerning a 20 year old female student with a history of migraine, asthma and allergies to acetaminophen, codeine, hydrocodone, sulfa, and VICODIN who on 20-MAR-2007, was vaccinated with a first dose 0.5ml dose of GARDASIL (lOT# 657006/0188u). On 20-MAR-2007 the patient experienced a severe headache. The patient went to the ER the day after receiving her vaccination. She reported feeling unclear during the injection and developed a diffuse headache, worse than a migraine and not relieved with MOTRIN or TORADOL. Laboratory diagnostic studies performed were a neurological exam and a CT scan which were both reported to be normal. The headache improved with DILAUDID. The patient was discharged with instructions to follow up with her primary care physician to continue GARDASIL series. Within on to two days, the patient recovered. On the morning of 21-MAY-2007, the patient received a second dose of the vaccine (Lot#657737/0522U) and no experience was reported. No product quality complaint was involved. It was reported that the patient''s headache was most likely a side effect from the vaccine. Additional information is not expected.


Changed on 6/14/2014

284165 Before After
VAERS Form:
Age:20.0
Gender:Female
Location:Unknown
Vaccinated:2007-03-30
Onset:2007-03-30
Submitted:2007-06-14
Entered:2007-06-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0188U / 0 UN / IM

Administered by: Other      Purchased by: Other
Symptoms: Computerised tomogram normal, Headache, Neurological examination

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit? (V2.0) No
Hospitalized? No
Previous Vaccinations:
Other Medications: Albuterol
Current Illness: Migraine; asthma; drug hypersensitivity; sulfonemdiea llergy; acetaminophen
Preexisting Conditions: Lung disorder; Neurological disorder NOS: Hypersensitivity
Allergies:
Diagnostic Lab Data: Neurological examination, normal; head computed axial, normal
CDC 'Split Type': WAES0705USA03896

Write-up:Information has been received from a registered nurse concerning a 20 year old female patient who on 30-MAR-2007 was vaccinated with a first 0.5ml dose of GARDASIL (Lot# 657006/0188U). On 30-MAR-2007 the patient experienced a severe headache. The patient went to the ER but it was not known if she was admitted. On an unspecified date, the patient recovered. On the morning of 21-MAY-2007 the patient received a second dose of the vaccine (Lot#657737/0522U) and no experience was reported. No product quality complaint was involved. Additional information has been requested. This is in follow-up to report (s) previously submitted on 6/14/2007. Information has been received from a registered nurse concerning a 20 year old female student with a history of migraine, asthma and allergies to acetaminophen, codeine, hydrocodone, sulfa, and VICODIN who on 20-MAR-2007, was vaccinated with a first dose 0.5ml dose of GARDASIL (lOT# 657006/0188u). On 20-MAR-2007 the patient experienced a severe headache. The patient went to the ER the day after receiving her vaccination. She reported feeling unclear during the injection and developed a diffuse headache, worse than a migraine and not relieved with MOTRIN or TORADOL. Laboratory diagnostic studies performed were a neurological exam and a CT scan which were both reported to be normal. The headache improved with DILAUDID. The patient was discharged with instructions to follow up with her primary care physician to continue GARDASIL series. Within on to two days, the patient recovered. On the morning of 21-MAY-2007, the patient received a second dose of the vaccine (Lot#657737/0522U) and no experience was reported. No product quality complaint was involved. It was reported that the patient''s headache was most likely a side effect from the vaccine. Additional information is not expected.


Changed on 5/14/2017

284165 Before After
VAERS Form:
Age:20.0
Gender:Female
Location:Unknown
Vaccinated:2007-03-30
Onset:2007-03-30
Submitted:2007-06-14
Entered:2007-06-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0188U / 0 UN / IM

Administered by: Other      Purchased by: Other
Symptoms: Computerised tomogram normal, Headache, Neurological examination

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit? (V2.0) No
Hospitalized? No
Previous Vaccinations:
Other Medications: Albuterol
Current Illness: Migraine; asthma; drug hypersensitivity; sulfonemdiea llergy; acetaminophen
Preexisting Conditions: Lung disorder; Neurological disorder NOS: Hypersensitivity
Allergies:
Diagnostic Lab Data: Neurological examination, normal; head computed axial, normal
CDC 'Split Type': WAES0705USA03896

Write-up:Information has been received from a registered nurse concerning a 20 year old female patient who on 30-MAR-2007 was vaccinated with a first 0.5ml dose of GARDASIL (Lot# 657006/0188U). On 30-MAR-2007 the patient experienced a severe headache. The patient went to the ER but it was not known if she was admitted. On an unspecified date, the patient recovered. On the morning of 21-MAY-2007 the patient received a second dose of the vaccine (Lot#657737/0522U) and no experience was reported. No product quality complaint was involved. Additional information has been requested. This is in follow-up to report (s) previously submitted on 6/14/2007. Information has been received from a registered nurse concerning a 20 year old female student with a history of migraine, asthma and allergies to acetaminophen, codeine, hydrocodone, sulfa, and VICODIN who on 20-MAR-2007, was vaccinated with a first dose 0.5ml dose of GARDASIL (lOT# 657006/0188u). On 20-MAR-2007 the patient experienced a severe headache. The patient went to the ER the day after receiving her vaccination. She reported feeling unclear during the injection and developed a diffuse headache, worse than a migraine and not relieved with MOTRIN or TORADOL. Laboratory diagnostic studies performed were a neurological exam and a CT scan which were both reported to be normal. The headache improved with DILAUDID. The patient was discharged with instructions to follow up with her primary care physician to continue GARDASIL series. Within on to two days, the patient recovered. On the morning of 21-MAY-2007, the patient received a second dose of the vaccine (Lot#657737/0522U) and no experience was reported. No product quality complaint was involved. It was reported that the patient''s headache was most likely a side effect from the vaccine. Additional information is not expected.


Changed on 9/14/2017

284165 Before After
VAERS Form:(blank) 1
Age:20.0
Gender:Female
Location:Unknown
Vaccinated:2007-03-30
Onset:2007-03-30
Submitted:2007-06-14
Entered:2007-06-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0188U / 0 1 UN / IM

Administered by: Other      Purchased by: Other
Symptoms: Computerised tomogram normal, Headache, Neurological examination

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit? (V2.0) No
Hospitalized? No
Previous Vaccinations:
Other Medications: Albuterol
Current Illness: Migraine; asthma; drug hypersensitivity; sulfonemdiea llergy; acetaminophen
Preexisting Conditions: Lung disorder; Neurological disorder NOS: Hypersensitivity
Allergies:
Diagnostic Lab Data: Neurological examination, normal; head computed axial, normal
CDC 'Split Type': WAES0705USA03896

Write-up:Information has been received from a registered nurse concerning a 20 year old female patient who on 30-MAR-2007 was vaccinated with a first 0.5ml dose of GARDASIL (Lot# 657006/0188U). On 30-MAR-2007 the patient experienced a severe headache. The patient went to the ER but it was not known if she was admitted. On an unspecified date, the patient recovered. On the morning of 21-MAY-2007 the patient received a second dose of the vaccine (Lot#657737/0522U) and no experience was reported. No product quality complaint was involved. Additional information has been requested. This is in follow-up to report (s) previously submitted on 6/14/2007. Information has been received from a registered nurse concerning a 20 year old female student with a history of migraine, asthma and allergies to acetaminophen, codeine, hydrocodone, sulfa, and VICODIN who on 20-MAR-2007, was vaccinated with a first dose 0.5ml dose of GARDASIL (lOT# 657006/0188u). On 20-MAR-2007 the patient experienced a severe headache. The patient went to the ER the day after receiving her vaccination. She reported feeling unclear during the injection and developed a diffuse headache, worse than a migraine and not relieved with MOTRIN or TORADOL. Laboratory diagnostic studies performed were a neurological exam and a CT scan which were both reported to be normal. The headache improved with DILAUDID. The patient was discharged with instructions to follow up with her primary care physician to continue GARDASIL series. Within on to two days, the patient recovered. On the morning of 21-MAY-2007, the patient received a second dose of the vaccine (Lot#657737/0522U) and no experience was reported. No product quality complaint was involved. It was reported that the patient''s headache was most likely a side effect from the vaccine. Additional information is not expected.


New Search

Link To This Search Result:

http://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=284165&WAYBACKHISTORY=ON


Copyright © 2018 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166